114799-13-2 (洛沙坦钾杂质C,Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol)

洛沙坦钾杂质C;(3-甲基丙烯酰胺丙基)三乙氧基硅烷;氯沙坦杂质C;洛沙坦杂质C;洛沙坦杂质C 标准品;氯沙坦钾EP杂质C;氯沙坦杂质 C;

Imp. C (EP): [2-Butyl-5-chloro-1-[[2'-(1Htetrazol-5-yl)biphenyl-4-yl]methyl]-1Himidazol-4-yl]methanol;[2-butyl-5-chloro-1-[[4-[2-(2H-tetrazol-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol;2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)[1,1'-biphenyl]-4-yl]methyl]-1H-imidazole-4-methanol;Losartan IMpurity C (Isolosartan);Losartan EP Impurity C (Isolosartan);(1-((2'-(1H-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol;SCHEMBL3121770;Losartan Potassium Imp. C (EP); Losartan Imp. C (EP); [2-Butyl-5-chloro-1-[[2'-(1H-tetrazol-5-yl)biphenyl-4-yl]methyl]-1H-imidazol-4-yl]methanol; Losartan Potassium Impurity C; Losartan Impurity C;1H-Imidazole-4-methanol, 2-butyl-5-chloro-1-((2'-(2H-tetrazol-5-yl)(1,1'-biphenyl)-4-yl)methyl)-;(2-butyl-5-chloro-1-{[2'-(1H-1,2,3,4-tetrazol-5-yl)-[1,1'-biphenyl]-4-yl]methyl}-1H-imidazol-4-yl)methanol;(2-Butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol,;(2-butyl-5-chloro-1-((2'-(1H-tetrazol-5-yl)biphenyl-4-yl)methyl)-1H-imidazol-4-yl)methanol;EN300-747209;UNII-ILI5UB76JR;Losartan Impurity C;114799-13-2;LOSARTAN POTASSIUM IMPURITY C [EP IMPURITY];ILI5UB76JR;Losartan potassium impurity C [EP];Z3279339299;Q27280782;(1-((2'-(2H-Tetrazol-5-yl)-[1,1'-biphenyl]-4-yl)methyl)-2-butyl-5-chloro-1H-imidazol-4-yl)methanol;[2-butyl-5-chloro-1-({4-[2-(1h-1,2,3,4-tetrazol-5-yl)phenyl]phenyl}methyl)-1h-imidazol-4-yl]methanol;

JWFIXKFLBIURBL-UHFFFAOYSA-N

1S/C22H23ClN6O/c1-2-3-8-20-24-19(14-30)21(23)29(20)13-15-9-11-16(12-10-15)17-6-4-5-7-18(17)22-25-27-28-26-22/h4-7,9-12,30H,2-3,8,13-14H2,1H3,(H,25,26,27,28)

ClC1=C(CO)N=C(CCCC)N1CC1C=CC(C2=CC=CC=C2C2N=NNN=2)=CC=1